Uni-Bio Science Group Limited (HKG:0690)
0.0600
-0.0020 (-3.23%)
Aug 27, 2026, 4:08 PM HKT
Uni-Bio Science Group Market Cap
Uni-Bio Science Group has a market cap or net worth of 358.27 million as of August 27, 2026. Its market cap has decreased by -59.73% in one year.
Market Cap
358.27M
Enterprise Value
346.99M
Revenue
549.77M
Ranking
n/a
PE Ratio
7.42
Stock Price
0.06
ChartMarket Cap Chart
Since November 12, 2001, Uni-Bio Science Group's market cap has increased from 1.02M to 358.27M, an increase of 35,025.46%. That is a compound annual growth rate of 26.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2026 | 358.27M | -47.83% |
| Dec 31, 2025 | 686.69M | 91.67% |
| Dec 31, 2024 | 358.27M | -20.75% |
| Dec 29, 2023 | 452.07M | -1.35% |
| Dec 30, 2022 | 458.26M | -14.08% |
| Dec 31, 2021 | 533.38M | -27.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| JW (Cayman) Therapeutics Co. | 872.67M |
| Kintor Pharmaceutical | 834.54M |
| Brii Biosciences | 743.46M |
| Cutia Therapeutics | 726.74M |
| 3D Medicines | 672.59M |
| Wuhan YZY Biopharma | 639.70M |
| B&K Corporation | 621.82M |
| Shanghai Bio-heart Biological Technology | 552.56M |